IM
IMCC.US Im Cannabis Corp
- Market cap
- USD 1.05M
- P/E
- -
- P/B
- 3.98x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is IMCC.US undervalued?
Graham numberThe Graham number of Im Cannabis Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Im Cannabis Corp fundamental analysis
No fundamental analysis for Im Cannabis Corp yet.
Im Cannabis Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Im Cannabis Corp
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Full company profileIm Cannabis Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Im Cannabis Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 4.39M | 5.20M | 9.07M | 15.9M | 34.1M | 54.3M | 48.8M | 54.0M | 54.7M | 32.5M |
| Gross Profit | - | 2.80M | 4.20M | 3.93M | 10.5M | 6.33M | 9.16M | 9.85M | 8.45M | 9.69M | 5.85M |
| Operating Income | -15.3K | -125K | 3.08M | -10.3M | -8.25M | -23.0M | -30.8M | -12.8M | -10.2M | -11.6M | -7.53M |
| EBITDA | -15.3K | -125K | 3.26M | -6.02M | -7.04M | 6.24M | -16.8M | -2.79M | -6.14M | -6.95M | -4.29M |
| Net Income | -15.8K | -125K | 1.68M | -7.29M | -28.7M | -17.8M | -189M | -9.50M | -10.6M | -11.3M | -13.3M |
| EPS | -11 | -83 | 18 | -410 | -1,339 | -552 | -4,735 | -133 | -135 | -80 | -1.43 |
| Balance Sheet | |||||||||||
| Total Assets | 276.00 | 9.14K | 37.0K | 30.9M | 38.1M | 287M | 60.7M | 48.8M | 39.2M | 31.7M | 24.7M |
| Total Liabilities | 432K | 466K | 252K | 4.79M | 25.5M | 82.4M | 36.9M | 35.1M | 36.0M | 35.4M | 30.4M |
| Shareholders' Equity | 11.4M | 11.4M | 10.2M | 24.7M | 11.1M | 201M | 22.7M | 14.5M | 5.24M | -858K | -5.55M |
| Cash & Short-term Investments | 170.00 | 4.03K | 37.0K | 13.9M | 8.89M | 13.9M | 2.45M | 1.81M | 863K | 2.73M | 1.74M |
| Total Debt | 6.44K | - | - | 1.05M | 990K | 29.3M | 11.5M | 13.8M | 18.0M | 16.3M | 13.9M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 0.00 | 525K | -431K | -5.96M | -7.92M | -34.4M | -12.6M | -8.08M | -1.08M | 4.72M | -3.01M |
| Capital Expenditure | 0.00 | 426K | 729K | 1.55M | 2.71M | 4.60M | 1.56M | 581K | 156K | 13.0K | 12.0K |
| Free Cash Flow | 0.00 | -522K | -775K | -7.51M | -10.6M | -39.0M | -14.2M | -8.66M | -1.23M | 4.70M | -3.02M |
| Ratios | |||||||||||
| ROE | -0.1% | -1.1% | 16.5% | -29.6% | -258.6% | -8.8% | -833.9% | -65.6% | -201.9% | - | - |
| ROA | -5,706.5% | -1,366.8% | 4,548.3% | -23.6% | -75.3% | -6.2% | -311.3% | -19.5% | -27.0% | -35.7% | -53.7% |
| Net Profit Margin | - | -2.8% | 32.4% | -80.4% | -180.6% | -52.2% | -347.6% | -19.5% | -19.6% | -20.7% | -40.8% |
| Debt to Equity | 0.00x | - | - | 0.04x | 0.09x | 0.15x | 0.51x | 0.95x | 3.44x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Im Cannabis Corp dividends
Im Cannabis Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 1:30 on Aug 27, 2026.
Who owns Im Cannabis Corp
- Insiders 34.40%
- Institutions 2.76%
- Public & others 62.85%
- Shares outstanding 1.84M
- Free float 357K
Top funds holding IMCC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Ninepoint Cannabis & Alt Health S A | 1.17K | 0.01% | 0.00% | Mar 2026 |
Top institutions holding IMCC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| HRT FINANCIAL LLC | 220K | 0.45% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 37.9K | 0.08% | 0.00% | Jun 2026 |
| StoneX Group Inc | 23.2K | 0.05% | 0.00% | Jun 2026 |
| Bank of Montreal | 12.1K | 0.02% | +1.69% | Jun 2026 |
| BMO Capital Markets Corp. | 12.1K | 0.02% | +1.69% | Jun 2026 |
| Federation des caisses Desjardins du Quebec | 1.90K | 0.00% | +0.05% | Jun 2026 |
| NATIONAL BANK OF CANADA /FI/ | 103.00 | 0.00% | 0.00% | Jun 2026 |
| Royal Bank of Canada | 70.00 | 0.00% | -1.41% | Jun 2026 |
| Advisor Group Holdings, Inc. | 33.00 | 0.00% | 0.00% | Jun 2026 |
| TD Waterhouse Canada Inc | 13.00 | 0.00% | +8.33% | Jun 2026 |
| Bryn Mawr Trust Company | 9.00 | 0.00% | 0.00% | Jun 2026 |
| UBS Group AG | 3.00 | 0.00% | 0.00% | Jun 2026 |
| Group One Trading, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Hidden Cove Wealth Management, LLC | 0.00 | 0.00% | -100.00% | Sep 2026 |
Im Cannabis Corp company profile
- Company name
- Im Cannabis Corp
- Ticker
- IMCC.US
- ISIN
- CA44969Q4060
- Exchange
- USA Stocks
- Listed since
- May 20, 2020
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 44
- Fiscal year end
- December
- Address
- 3606 ? 833 Seymour Street, Vancouver, BC, Canada, V6B 0G4
- Phone
- 972 5 44331111
- Website
- imcannabis.com
About Im Cannabis Corp
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Im Cannabis Corp management
5- Mr. Oren ShusterCEO & Executive Director · born 1969
- Mr. Asi LeviChief Financial Officer · born 1980
- Mr. Richard BallaChief Executive Officer of Adjupharm · born 1986
- Anna TarankoDirector Investor & Public Relations
- Mr. Eyal FisherChief Executive Officer of the IMC Holdings